drugset / Trial / NCT02145520

Efficacy of Magnesium Sulfate in the Treatment of Bronchiolitis

NCT02145520

Phase 2 Completed 200 enrolled Hamad Medical Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

In this study, investigators will compare the efficacy and safety of intravenous (IV) Magnesium sulfate in decreasing bronchiolitis clinical severity score and the duration of hospitalization in admitted patients, as compared to placebo.

Timeline

Start
2012-10
Primary completion
2015-05
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 100 mg/kg Intravenous

Indications